GlobeNewswire (Wed, 4:00PM)
Quote & Headlines
Market Currents
StockTalk
Description
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
881 people get AMRS articles and Market Currents by email alert.
Get email alerts on AMRS »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (May 13, 2013)
-
-
GlobeNewswire (Apr 30, 2013)
-
-
GlobeNewswire (Apr 16, 2013)
-
GlobeNewswire (Apr 15, 2013)
-
GlobeNewswire (Apr 11, 2013)
-
GlobeNewswire (Apr 5, 2013)
-
-
GlobeNewswire (Apr 1, 2013)
-
-
GlobeNewswire (Mar 21, 2013)
-
GlobeNewswire (Mar 14, 2013)
-
GlobeNewswire (Mar 11, 2013)
-
GlobeNewswire (Feb 19, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
Top 5 Insider Buys Filed On September 5Markus Aarnio • Thu, Sep 6, 2012
-
-
-
-
-
-
-
-
Amyris' CEO Discusses Q3 2012 Results - Earnings Call TranscriptTue, Nov 6, 2012
-
Amyris Management Discusses Q2 2012 Results - Earnings Call TranscriptTue, Jul 31, 2012
-
GlobeNewswire (Wed, 4:00PM)
-
GlobeNewswire (May 13, 2013)
-
GlobeNewswire (Apr 30, 2013)
-
GlobeNewswire (Apr 16, 2013)
-
GlobeNewswire (Apr 15, 2013)
-
GlobeNewswire (Apr 11, 2013)
-
GlobeNewswire (Apr 5, 2013)
-
GlobeNewswire (Apr 1, 2013)
-
GlobeNewswire (Mar 21, 2013)
-
GlobeNewswire (Mar 14, 2013)
-
GlobeNewswire (Mar 11, 2013)
-
GlobeNewswire (Feb 19, 2013)
-
GlobeNewswire (Feb 19, 2013)
-
GlobeNewswire (Feb 1, 2013)
-
GlobeNewswire (Jan 15, 2013)
-
GlobeNewswire (Dec 27, 2012)
-
GlobeNewswire (Nov 6, 2012)
-
GlobeNewswire (Oct 16, 2012)
-
GlobeNewswire (Oct 9, 2012)
AMRS vs. ETF Alternatives
Company Description
Currently, there's no company description for AMRS.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 16, 10:59 AM Amyris (AMRS -5.6%) takes a hit after the company is implicated in a class action lawsuit which claims it misled investors in 2011 and 2012 about its ability to produce Biofene in "commercially meaningful volumes." When the company changed its tone about production levels, the stock ultimately fell 48% from November 2011 to February 2012. (PR) Comment! [Healthcare, On the Move]
- Tuesday, April 30, 4:08 PM Amyris (AMRS): Q1 EPS of -$0.39 in-line. Revenue of $7.9M misses by $1.9M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, April 30, 12:10 AM Notable earnings after Tuesday’s close: ACAS, AFFX, AJG, AMRS, APU, ATLS, AUY, AVB, BCOV, BGC, BLMN, BXP, CAVM, CLD, CRAY, DDR, DENN, DGI, DWA, EEP, EIX, ELGX, ELLI, ENTR, EQR, EZPW, FEIC, FIRE, FISV, FLEX, FMC, FTNT, GDOT, GEVO, GNW, HCBK, HT, HTCH, IACI, INT, JIVE, JLL, JMBA, LEAP, MDU, MERU, MRGE, MSPD, MTW, MWA, MX, NANO, NCR, NUVA, OKE, OKS, PRAA, PRXL, QCOR, QEP, REXX, RGC, RPXC, SGI, SHOR, SIMG, SKT, SM, SONS, STR, SWI, TE, TRMB, TRN, UGI, ULTI, UNTD, UNXL, VNR, VRSK, VRTX, WNC, WRI, WU, XCO Comment! [Earnings]
- Monday, April 29, 5:35 PM Notable earnings after Tuesday’s close: ACAS, AFFX, AJG, AMRS, APU, ATLS, AUY, AVB, BCOV, BGC, BLMN, BXP, CAVM, CLD, CRAY, DDR, DENN, DGI, DWA, EEP, EIX, ELGX, ELLI, ENTR, EQR, EZPW, FEIC, FIRE, FISV, FLEX, FMC, FTNT, GDOT, GEVO, GNW, HCBK, HT, HTCH, IACI, INT, JIVE, JLL, JMBA, LEAP, MDU, MERU, MRGE, MSPD, MTW, MWA, MX, NANO, NCR, NUVA, OKE, OKS, PRAA, PRXL, QCOR, QEP, REXX, RGC, RPXC, SGI, SHOR, SIMG, SKT, SM, SONS, STR, SWI, TE, TRMB, TRN, UGI, ULTI, UNTD, UNXL, VNR, VRSK, VRTX, WNC, WRI, WU, XCO 2 Comments [Earnings]
-
Thursday, April 11, 9:10 AM
Premarket gainers: ACAD +43%. AMRS +15%. STEM +12%. RAD +12%. AEZS +11%. BYD +7%. BDSI +6%.
Losers: FTNT -18%. AFFY -10%. SGYP -10%. HPQ -6%. Comment! [On the Move] - Thursday, April 11, 8:12 AM Amyris (AMRS) gets a lift before the bell as the company says its scientists used "simple baker's yeast strains to produce unprecedented concentrations of the precursor to the anti-malarial drug ingredient Artemisinin." Sanofi says it will use the semisynthetic artemisinin to produce between 80-150M ACT malaria treatments per year by 2014. AMRS shares +15.3% premarket. Comment! [Healthcare, On the Move]
- Tuesday, February 19, 4:07 PM Amyris (AMRS): Q4 EPS of -$0.49 misses by $0.08. Revenue of $5.9M misses by $4.78M. Shares +1.6% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Tuesday, February 19, 12:10 AM Notable earnings after Tuesday’s close: ADI, AMRS, ANAD, BAS, BJRI, CF, DELL, DX, FNF, GTAT, HLF, LLNW, MAR, MDRX, MM, NBR, NFX, QEP, SHO, SINA, TEX, ZIXI Comment! [Earnings]
- Monday, February 18, 5:35 PM Notable earnings after Tuesday’s close: ADI, AMRS, ANAD, BAS, BJRI, CF, DELL, DX, FNF, GTAT, HLF, LLNW, MAR, MDRX, MM, NBR, NFX, QEP,SHO, SINA, TEX, ZIXI Comment! [Earnings]
- Tuesday, February 12, 9:58 AM Amyris (AMRS -8%) shares plunge after a Raymond James downgrade following a recent run-up the firm says is unwarranted. AMRS has been in the penalty box since disclosing scale-up delays and withdrawing guidance a year ago. "Amyris' scale-up issues do not permanently condemn the technology platform, but it will clearly take time for visibility to re-emerge," the firm says. Comment! [Energy, Quick Ideas, On the Move]
- Friday, February 1, 4:40 PM Shares of biofuels and ethanol companies surged for a second day after the EPA proposed increasing required use of renewable fuels: GEVO +10%, PEIX +6.1%, GPRE +3.4%, REGI +2.3%, BIOF +1.5%. Also, renewable fuel producer Amyris (AMRS +5.2%) said its plant in Brazil made its first commercial shipment of farnesene, used in specialty chemicals and fuels. 2 Comments [Energy]
- Thursday, January 31, 3:11 PM Biofuel Energy (BIOF +15.1%) and Pacific Ethanol (PEIX +12.4%) are among biofuel and ethanol stocks surging as the EPA raises standards for biomass-based diesel, advanced biofuels, cellulosic biofuels and total renewable fuels. Also: REGI +5.7%, GPRE +2.7%, AMRS +2%. Comment! [Energy, On the Move]
-
Wednesday, January 16, 12:45 PM
Midday top 10 gainers: CLRO +49%. NVTL +17%. HPTX +16%. FSGI +16%. CBK +14%. PLBC +13%. BOSC +13%. FSI +12%. CYTR +10%. ADES +10%.
Midday top 10 Losers: GALT -9%. LODE -8%. AMRS -8%. PGNX -8%. IRWD -7%. CROX -7%. GDOT -7%. AXX -7%. YOD -7%. AIM -7%. Comment! [On the Move] - Wednesday, January 2, 10:12 AM Biofuel firms enjoy notable strength in early trading, as the fiscal cliff deal includes relief for all sorts of renewable energy. BIOF +24.7%, SYNM +24.1%, GEVO +10.4%, REGI +9.2%, SZYM +5.9%, PEIX +4.8%, FF +4%, AMRS +3.9%, ADM +3.4%, KIOR +2.7%. Comment! [Energy, On the Move]
-
Monday, December 31, 2012, 12:45 PM
Midday top 10 gainers: UNXL +22%. AMRS +21%. DUF +20%. PTEK +17%. FFNM +17%. LXRX +15%.FORD +15%. ALJ +15%. PMFG +12%. EXE +12%.
Midday top 10 Losers: EMITF -13%. CFBK -12%. MARK -10%. CALM -10%. DLIA -10%. BIOF -9%.LTBR -9%. GRH -9%. WSBF -8%.FSI -8%. Comment! [On the Move] - Monday, December 31, 2012, 10:06 AM Amyris Biotechnologies (AMRS +16%) bounces big, maybe on word 3 company insiders took down more than one-third of last week's $42.25M private placement. Among them were former Qatar PM Sheikh Abdullah bin Khalifa Al Thani who more than doubled his stake, and now owns 8% of the company. Comment! [Energy, On the Move]
-
- View all 1 replies
-
vireoman: So the spraying of Afrezza into one's nose evidently doesn't contribute to global warming?
-
Ryan Mallory
Fuinhaz Setups for April 11 2013 | $AEZS $AMRS $ASML $CETV $GRPN $NFLX $VOD $ZNGA | http://bit.ly/YNtwJP - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
freefdawatchlist
http://bit.ly/TKA3lp Premarket Gainer and losers for Nov 7th: $VHC, $AMRS, $FCAL, $PLXS, $LPSN, $JRCC - View all 0 replies
-
freefdawatchlist
http://bit.ly/RU6xG2 After hour gainers and losers for Nov 6th: $PLXS, $SPPI, $IQNT, $AMRS,$SGI, $REGI - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 6 replies
-
-
LATEST REPLIES
